Blood Testing Market Size, Share, Growth Analysis, By Type (Glucose Testing, Lipid Panel Testing), By Methods (Manual Blood Testing, Automated Blood Testing), By End User, By Region - Industry Forecast 2026-2033

Blood Testing Market size was valued at USD 103.14 Billion in 2024 and is poised to grow from USD 110.87 Billion in 2025 to USD 197.74 Billion by 2033, growing at a CAGR of 7.5% during the forecast period (2026–2033).

The global blood testing market is highly fragmented in the nature with the presence of several big players such as Danaher Corporation, Abbott Laboratories, BioRad Laboratories. These key players are implanting on certain strategies such as merger, acquisition, new product launch, partnerships, which help them to consolidate and strengthening their market position. For instance, in June 2022, Apollo Cancer Centres in partnership with Datar Cancer Genetics launched a type of blood test that can detect breast cancer at early stages in asymptomatic individuals. 'Abbott ', 'F. Hoffmann-La Roche Ltd ', 'Bio-Rad Laboratories, Inc. ', 'bioMerieux ', 'Quest Diagnostics Incorporated ', 'Biomerica ', 'BD ', 'Siemens Healthineers AG ', 'Danaher Corporation ', 'Trinity Biotech Plc ', 'Thermo Fisher Scientific ', 'Sysmex Corporation ', 'Dr Lal PathLabs Limited ', 'Alere Inc. ', 'Cepheid Corporation '

External funding for the clinical studies aimed at developing new and advanced technology in diagnostic tests is a major driver to the growth of the market.

Key players in the global blood testing market are focusing on new and innovative ways to make their products and to introduce more effectively for the end-users. The use of latest technology such as Artificial Intelligence to detect accurate results at early stage of a disease is having positive impact on the end-users.

North America dominated the global blood testing market and accounted for the largest revenue share of over 45% in 2021. A rise in the number of strategic activities which are being undertaken by several market players and government bodies to increase the donation of plasma in the region is one of the major factors driving the market growth over the forecast period. The United States topped in the export value blood testing instruments in 2021. In the United States, the export value for blood testing instruments was USD 27,782,430 thousand in 2020 which rises to USD 30,967,176 thousand in 2021 with an annual growth rate of 11%. The increasing number of blood donations is further anticipated to fuel the demand for the testing products in the region.